ZA986874B - Alatrofloxacin parenteral compositions. - Google Patents

Alatrofloxacin parenteral compositions.

Info

Publication number
ZA986874B
ZA986874B ZA9806874A ZA986874A ZA986874B ZA 986874 B ZA986874 B ZA 986874B ZA 9806874 A ZA9806874 A ZA 9806874A ZA 986874 A ZA986874 A ZA 986874A ZA 986874 B ZA986874 B ZA 986874B
Authority
ZA
South Africa
Prior art keywords
alatrofloxacin
parenteral compositions
parenteral
compositions
alatrofloxacin parenteral
Prior art date
Application number
ZA9806874A
Other languages
English (en)
Inventor
Robert Mark Guinn
John Francis Lambert
Subramanian Sam Guhan
Stanley Walter Walinsky
Original Assignee
Pfizer Prod Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer Prod Inc filed Critical Pfizer Prod Inc
Publication of ZA986874B publication Critical patent/ZA986874B/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D519/00Heterocyclic compounds containing more than one system of two or more relevant hetero rings condensed among themselves or condensed with a common carbocyclic ring system not provided for in groups C07D453/00 or C07D455/00
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K5/00Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/06Dipeptides
    • C07K5/06008Dipeptides with the first amino acid being neutral
    • C07K5/06017Dipeptides with the first amino acid being neutral and aliphatic
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K5/00Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/06Dipeptides
    • C07K5/06191Dipeptides containing heteroatoms different from O, S, or N
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Peptides Or Proteins (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Medicinal Preparation (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
ZA9806874A 1997-08-01 1998-07-31 Alatrofloxacin parenteral compositions. ZA986874B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US5424697P 1997-08-01 1997-08-01

Publications (1)

Publication Number Publication Date
ZA986874B true ZA986874B (en) 2000-01-31

Family

ID=21989735

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA9806874A ZA986874B (en) 1997-08-01 1998-07-31 Alatrofloxacin parenteral compositions.

Country Status (40)

Country Link
US (1) US6194429B1 (fr)
EP (1) EP1000086B1 (fr)
JP (1) JP3463928B2 (fr)
KR (1) KR20010022495A (fr)
CN (1) CN1265671A (fr)
AP (1) AP1031A (fr)
AR (1) AR015417A1 (fr)
AT (1) ATE259827T1 (fr)
AU (1) AU734863B2 (fr)
BG (1) BG104105A (fr)
BR (1) BR9811580A (fr)
CA (1) CA2296466C (fr)
CO (1) CO4970688A1 (fr)
DE (1) DE69821767T2 (fr)
DK (1) DK1000086T3 (fr)
DZ (1) DZ2576A1 (fr)
EA (1) EA002120B1 (fr)
ES (1) ES2214716T3 (fr)
GT (1) GT199800112A (fr)
HN (1) HN1998000106A (fr)
HR (1) HRP980417B1 (fr)
HU (1) HUP0004793A3 (fr)
ID (1) ID24374A (fr)
IL (1) IL134156A0 (fr)
IS (1) IS5339A (fr)
MA (1) MA24626A1 (fr)
NO (1) NO20000485L (fr)
NZ (1) NZ502249A (fr)
OA (1) OA11281A (fr)
PA (1) PA8456701A1 (fr)
PE (1) PE103799A1 (fr)
PL (1) PL338477A1 (fr)
PT (1) PT1000086E (fr)
SK (1) SK1012000A3 (fr)
TN (1) TNSN98146A1 (fr)
TW (1) TW538043B (fr)
UY (1) UY25113A1 (fr)
WO (1) WO1999006430A1 (fr)
YU (1) YU2500A (fr)
ZA (1) ZA986874B (fr)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE285821T1 (de) * 1999-10-08 2005-01-15 Affinium Pharm Inc Fab i inhibitoren
EP1121933A1 (fr) * 2000-02-02 2001-08-08 Pfizer Products Inc. Compositions prémélangées injectables d'alatrofloxacin
CA2444597A1 (fr) 2001-04-06 2002-10-06 Affinium Pharmaceuticals, Inc. Inhibiteurs de fab i
EP1575951B1 (fr) 2002-12-06 2014-06-25 Debiopharm International SA Composes heterocycliques, procedes de production de ceux-ci et utilisation de ceux-ci dans un traitement
DE602004016831D1 (de) 2003-03-17 2008-11-13 Affinium Pharm Inc Pharmazeutische zusammensetzungen inhibitoren von fab i und weitere antibiotika enthaltend
CA2467321A1 (fr) * 2004-05-14 2005-11-14 Paul J. Santerre Agents de couplage polymeres et polymeres ayant une activite pharmaceutique produits a partir de ceux-ci
EP2848614A3 (fr) 2004-06-04 2015-07-29 Debiopharm International SA Dérivés de acrylamide et leur utilisation comme agents antibiotiques
EP1973902A2 (fr) * 2005-12-05 2008-10-01 Affinium Pharmaceuticals, Inc. Agents therapeutiques et ses procédés de fabrication et d utilisation
EP2687533B1 (fr) 2006-07-20 2017-07-19 Debiopharm International SA Dérivés d'acrylamide en tant qu'inhibiteurs de FAB I
WO2008098374A1 (fr) 2007-02-16 2008-08-21 Affinium Pharmaceuticals, Inc. Sels, promédicaments et polymorphes d'inhibiteurs de fab 1
SI2861608T1 (sl) 2012-06-19 2019-08-30 Debiopharm International Sa Derivati predzdravila (E)-N-metil-N-((3-metilbenzofuran-2-IL)metil)- 3-(7-okso-5,6,7,8-tetrahidro-1 ,8-nafthiridin-3-il)akrilamid
EP3134103B1 (fr) * 2014-04-25 2020-01-15 Naurex Inc. Compositions stables de peptides neuroactifs
BR122023021456A2 (pt) 2016-02-26 2024-02-20 Debiopharm International S.A. Uso de di-hidrogeno fosfato de {6- [(e)-3-{metil[(3-metil-1-benfofuran-2- iol)metil]amino)-3- oxopro-1-en-1-il]-2-oxo-3,4-di-hidro-1,8-naftiridin-1(2h)- il}metila para tratamento de osteomielite do pé diabético e composição farmacêutica
CN111971292B (zh) 2018-02-02 2024-12-13 波纹疗法公司 包含类固醇二聚体的玻璃制剂及其用途
WO2020154815A1 (fr) 2019-02-01 2020-08-06 Ripple Therapeutics Corporation Formes cristallines de dimères de dexaméthasone et leurs utilisations
LT3923914T (lt) 2019-02-14 2023-07-25 Debiopharm International S.A. Afabicino kompozicija, jos gamybos būdas
CN113939306B (zh) 2019-06-14 2024-07-19 德彪药业国际股份公司 用于治疗涉及生物膜的细菌感染的药物及其用途
WO2021024041A1 (fr) 2019-08-07 2021-02-11 Ripple Therapeutics Corporation Dimères de médicaments à libération contrôlée
MX2022013665A (es) 2020-05-01 2022-11-30 Ripple Therapeutics Corp Composiciones y metodos heterodimeros para el tratamiento de trastornos oculares.

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3713672A1 (de) 1987-04-24 1988-11-17 Bayer Ag Verfahren zur herstellung von parenteral verabreichbaren chinoloncarbonsaeuren
US5164402A (en) 1989-08-16 1992-11-17 Pfizer Inc Azabicyclo quinolone and naphthyridinone carboxylic acids
US5256791A (en) 1992-03-02 1993-10-26 Pfizer Inc. Preparation of intermediates in the synthesis of quinoline antibiotics
CZ286896B6 (en) 1994-01-18 2000-07-12 Pfizer Process for preparing pharmaceutically acceptable salts of naphthyridone carboxylic acid and intermediates for this preparation
TW420610B (en) 1994-04-07 2001-02-01 Pfizer A pharmaceutical composition for treating a H. pylori infection or gastric or duodenal ulcers
US5475116A (en) 1994-04-29 1995-12-12 Pfizer Inc. Aza bicyclo[3,1,0]hexane intermediates useful in the synthesis of quinolones
US5763454A (en) 1995-06-06 1998-06-09 Pfizer, Inc. Crystal form of anhydrous 7-( 1α,5α,6α!-6-amino-3-azabicyclo 3.1.0!hex-3-yl)-6-fluoro-1-(2,4-difluorophenyl)-1,4-dihydro-4-oxo-1,8 naphthyridine-3-carboxylic acid, methanessulfonic acid salt
ATE221544T1 (de) * 1995-06-15 2002-08-15 Pfizer Verfahren zur herstellung von derivaten der ein peptid enthaltenden azabizylo-naphtyridin- carbonsäure
SK23898A3 (en) 1995-08-29 1999-05-07 Pfizer Zwitterionic forms of trovafloxacin
DE69617027T2 (de) * 1995-08-29 2002-03-21 Pfizer Inc., New York Polymorphs von prodrug 6-n(l-ala-l-ala)-trovafloxacin
GB9524466D0 (en) 1995-11-30 1996-01-31 Pfizer Ltd Process
JPH1087617A (ja) 1996-07-09 1998-04-07 Pfizer Inc キノリン系抗生物質の合成に有用な中間体の製法

Also Published As

Publication number Publication date
HRP980417A2 (en) 1999-08-31
JP3463928B2 (ja) 2003-11-05
TNSN98146A1 (fr) 2005-03-15
BG104105A (bg) 2000-08-31
EA200000086A1 (ru) 2000-08-28
JP2001512133A (ja) 2001-08-21
HUP0004793A3 (en) 2001-10-29
DK1000086T3 (da) 2004-05-17
BR9811580A (pt) 2000-08-22
NO20000485D0 (no) 2000-01-31
NO20000485L (no) 2000-03-27
IS5339A (is) 2000-01-14
GT199800112A (es) 2000-01-15
EP1000086A1 (fr) 2000-05-17
EA002120B1 (ru) 2001-12-24
AU8236898A (en) 1999-02-22
CO4970688A1 (es) 2000-11-07
YU2500A (sh) 2002-09-19
HUP0004793A2 (hu) 2001-04-28
AR015417A1 (es) 2001-05-02
US6194429B1 (en) 2001-02-27
ATE259827T1 (de) 2004-03-15
DZ2576A1 (fr) 2003-02-22
NZ502249A (en) 2001-11-30
ID24374A (id) 2000-07-13
DE69821767T2 (de) 2005-01-13
KR20010022495A (ko) 2001-03-15
IL134156A0 (en) 2001-04-30
AP1031A (en) 2001-12-21
OA11281A (en) 2002-11-19
DE69821767D1 (de) 2004-03-25
AU734863B2 (en) 2001-06-21
PL338477A1 (en) 2000-11-06
CA2296466A1 (fr) 1999-02-11
TW538043B (en) 2003-06-21
SK1012000A3 (en) 2000-09-12
EP1000086B1 (fr) 2004-02-18
CN1265671A (zh) 2000-09-06
WO1999006430A1 (fr) 1999-02-11
PA8456701A1 (es) 2000-05-24
CA2296466C (fr) 2003-04-15
HRP980417B1 (en) 2002-10-31
AP9801310A0 (en) 1998-09-30
ES2214716T3 (es) 2004-09-16
HN1998000106A (es) 1999-01-08
PT1000086E (pt) 2004-05-31
MA24626A1 (fr) 1999-04-01
PE103799A1 (es) 1999-10-25
UY25113A1 (es) 2000-12-29

Similar Documents

Publication Publication Date Title
ZA984849B (en) Compositions.
ZA989767B (en) Novel compounds.
ZA975735B (en) Pesticidal compositions.
ZA976119B (en) Pesticidal compositions.
ZA978178B (en) Composition.
ZA987536B (en) Stanol comprising compositions.
ZA986874B (en) Alatrofloxacin parenteral compositions.
ZA975261B (en) Composition.
ZA981574B (en) Hard-surface cleaning compositions.
ZA991272B (en) Novel thiobenzamides.
GB9702238D0 (en) Compositions
ZA9811572B (en) Novel anti-diabetic composition.
ZA9811502B (en) Novel composition.
ZA972179B (en) Fuel compositions.
ZA9811758B (en) Novel compounds.
ZA9811503B (en) Novel compounds.
ZA973045B (en) Pesticidal compositions.
ZA200006118B (en) Novel composition.
ZA98868B (en) Novel compounds.
ZA200000192B (en) Novel composition.
GB9705340D0 (en) Compositions
ZA981739B (en) Composition.
ZA975895B (en) Ceramic compositions.
ZA973627B (en) Pesticidal compositions.
GB9703109D0 (en) Compositions